Global Bio-Implants Market, By Product Type (Orthopaedics and Trauma, Pacing Devices, Stents and Related Implants, Spinal Implants, Ophthalmic Implants, Structural Cardiac Implants, Dental Implants, Neurostimulators Implants and Prosthetic Implants), Type (Allograft, Autograft, Xenograft and Synthetic), Material (Biomaterial Metal, Alloy, Polymer, Ceramics and Acrylic Hydrogel), Mode of Administration (Surgical and Non-Surgical), End-User (Clinics, Hospitals and Ambulatory Surgical Centres), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights: Global Bio-Implants Market
Data Bridge Market Research analyses that the bio-implants market to growing at a CAGR of 8.30% in the forecast period of 2022-2029.
Bio-implants are biosynthetic substances used in medical applications to repair broken or fractured bones, replace a bone, or aid in the healing of a damaged bone. The primary function of implant fabric is to provide balance to bone fractures and assist with within the organic components of bone recuperation by minimising micro-movement at the bone-implant interface. The metals used in bio-implants are typically titanium and its alloys, which are widely used as surgical implants due to their high corrosion resistance, high unique energy, and biocompatibility.
Increased cases of bone diseases or fractured bones, as well as cardiovascular, orthopaedic, and spinal disorders, are expected to drive growth in the global bio-implants market. Furthermore, rising surgical procedure range, rising healthcare expenditure, rising geriatric population, rising sports-related injuries, rising scientific facilities, rising occurrence of chronic illness are a few other factors that may boost the global bio-implants market.
Furthermore, technological advancements in surgical products, as well as an increase in the number of accidents, are a few other factors driving market growth. The high cost of implants, regulatory scenario, and unfavourable reimbursement policies are the major restraining factors that will create a lot of hindrance for the market. The growing number of diagnostic centres and clinics, as well as emerging countries and rising medical tourism, are among the major opportunities.
However, the high cost of implants, as well as reimbursement issues, are some of the factors impeding market growth most challenging factors are the side effects of various cosmetic surgeries, as well as the scarcity of trained professionals.
This bio-implants market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on bio-implants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Bio-Implants Market Scope and Market Size
The bio-implants market is segmented on the basis of product type, type, material, mode of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product type, the bio-implants market is segmented into orthopaedics and trauma, pacing devices, stents and related implants, spinal implants, ophthalmic implants, structural cardiac implants, dental implants, neurostimulators implants, prosthetic implants, and others.
- Based on type, the bio-implants market is segmented into allograft, autograft, xenograft, synthetic, and others.
- Based on material, the bio-implants market is segmented into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel.
- Based on mode of administration, the bio-implants market is segmented into surgical and non-surgical.
- Based on end users, the bio-implants market is segmented into hospitals, ambulatory surgical centres, clinics, and others.
Bio-Implants Market Country Level Analysis
The bio-implants market is analysed and market size insights and trends are provided by country, product type, type, material, mode of administration and end users as referenced above.
The countries covered in the bio-implants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the global bio-implants market due to factors such as an increase in the number of surgical procedures requiring implants and an increase in the adoption of advanced technologies across various medical disciplines. Asia-Pacific is expected to be the fastest-growing market during the forecast period, owing to the high prevalence of spinal cord injuries. This can be attributed to an alarming increase in the number of road accidents.
The country section of the bio-implants market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The bio-implants market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bio-implants market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bio-implants market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Bio-Implants Market Share Analysis
The bio-implants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bio-implants market.
Some of the major players operating in the bio-implants market are Medtronic, Stryker, Wright Medical Group N.V., Zimmer Biomet., Smith+Nephew, Boston Scientific Corporation, Organogenesis Inc., Arthrex, Inc., Orthofix Medical Inc., Cochlear Ltd., Exactech, Inc., Arthrex, Inc., LifeNet Health, Nobel Biocare Services AG., Clinique Dentaire de Lausanne-Centre., Alpha-Bio Tec Ltd., Osprey Medical Inc., Abbott and MIMEDX. among others.